Australia's largest stock trading and investment forum Australia's #1 stock forum

GSS

Click for more information

2.17%

67.5¢ genetic signatures limited

Many thanks, dotterell. I am of physics training, not...

First 27 Last

Share
Profile

Follow
jigsawjing

14 Posts.

04/06/18

19:06

Post #: 33484864
Share

Originally posted by dotterell ↑

Jigsaw,
A grain of salt is needed for info of scientific nature on HC not backed by examples and references.
On p3 of the recent Investor Presentation the 3-base method is explained. It occurs prior to the PCR test and modifies the microbial DNA present in a patient sample. After that a standard PCR reaction occurs. There is no reason why it shouldn't be applicable to all types of infectious disease PCR testing (virtually all infections are caused by microbes).
If you are interested to read about the market for diagnostic PCR tests the online magazine Medical Laboratory Observer might be helpful, using the search terms 'multiplex PCR' or 'molecular diagnostics'.
Multiplex PCR detects multiple pathogens in one test and this has inherent challenges (as opposed to detecting one pathogen in a test). As you should see from MLO, it is a relatively recent development. 3-base technology is one approach to address the challenges of multiplex PCR by reducing the complexity of the target DNA.

Expand

Many thanks, dotterell. I am of physics training, not biochemistry. Your analysis is very much appreciated.

GSS Price at posting: 40.0¢ Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

HotCopper Highlights: Your most watched stocks for Week 48, 2024

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

There are more pages in this discussion • 2 more messages in this thread...

First 27 Last

Add GSS (ASX) to my watchlist

(20min delay)
Last 67.5¢		Change -0.015(2.17%)		Mkt cap ! $155.4M

Open	High	Low	Value	Volume
68.5¢	68.5¢	67.5¢	$8.27K	12.21K

Buyers (Bids)

No.	Vol.	Price($)
2	34322	67.5¢

Sellers (Offers)

Price($)	Vol.	No.
68.5¢	7757	1

View Market Depth

No.	Vol.	Price($)
1	15000	0.710
2	10880	0.680
1	100000	0.650
1	1627	0.615
0	0	0.000

Price($)	Vol.	No.
0.740	15725	2
0.750	22017	2
0.760	39008	2
0.800	500	1
0.810	40999	1

Last trade - 13.57pm 29/11/2024 (20 minute delay)

GSS (ASX) Chart